New Discharge Aid Improves Transitions for Dementia Patients, Study Reveals
Researchers at the University of Manchester have developed and evaluated SAFER-Dem, a redesigned care bundle aimed at improving the often-challenging hospital discharge process for individuals with dementia. Published this week in BMJ Open, the intervention demonstrates a patient-centered approach to safer, more coordinated care transitions, aligning with NHS goals for enhanced dementia support.
The discharge process represents a particularly vulnerable period for individuals living with dementia. Disrupted routines, unfamiliar environments, and complex medication regimens can exacerbate cognitive impairment and increase the risk of adverse events, including hospital readmissions. SAFER-Dem directly addresses these challenges by prioritizing clear communication, shared decision-making, and personalized support.
In Plain English: The Clinical Takeaway
- Better Communication: SAFER-Dem helps doctors and nurses talk to people with dementia and their families in a way that’s easier to understand, especially about medications.
- More Involvement: The tool encourages patients with dementia to be more involved in planning their care after leaving the hospital, respecting their wishes, and preferences.
- Reduced Confusion: By providing clear information and support, SAFER-Dem aims to reduce confusion and anxiety during the transition from hospital to home.
The Evolution of SAFER: From General Patient Flow to Dementia-Specific Care
The SAFER-Dem intervention builds upon existing “care bundles” – sets of evidence-based practices designed to improve patient safety and quality of care. The original SAFER patient flow bundle, developed by NHS Improvement, focuses on reducing delays and improving overall patient safety in adult inpatient wards. Recognizing the unique needs of patients with mental health conditions, researchers at the University of Manchester adapted this bundle into SAFER-Mental Health (SAFER-MH). Still, SAFER-MH still lacked specific considerations for dementia.
This led to a co-design approach, where researchers collaborated directly with individuals living with dementia, their caregivers, and healthcare professionals. Through workshops and interviews involving 29 participants, they identified key areas for improvement, resulting in the creation of SAFER-Dem. Participants consistently highlighted issues with unclear communication, insufficient information, and a lack of involvement in discharge planning. Medication management emerged as a particularly significant concern.
Clinical Evidence and the Mechanism of Action
The study, funded by the National Institute for Health and Care Research (NIHR) and the NIHR Greater Manchester Patient Safety Research Collaboration (GM PSRC), demonstrates the potential of SAFER-Dem to enhance patient safety and system resilience. The core mechanism of action revolves around improved interprofessional communication and patient engagement. By standardizing the discharge process and incorporating dementia-specific considerations, SAFER-Dem reduces the likelihood of critical information being overlooked or misinterpreted. This, in turn, minimizes the risk of medication errors, missed follow-up appointments, and preventable readmissions.
Globally, an estimated 55 million people live with dementia, with approximately 10 million new cases diagnosed annually, according to the World Health Organization (WHO). In the United Kingdom, the NHS estimates that over 900,000 people are living with dementia, and this number is projected to rise significantly in the coming decades (NHS). Effective discharge planning is crucial for managing this growing public health challenge. The current standard of care often falls short, contributing to a high rate of post-discharge complications and readmissions. A 2022 study published in The Lancet found that nearly 25% of patients with dementia are readmitted to hospital within 30 days of discharge (The Lancet).
Geographical Impact and NHS Integration
The SAFER-Dem intervention aligns directly with the goals outlined in the NHS 10-Year Health Plan for England, which prioritizes improved care for individuals with dementia and their families. The plan emphasizes the importance of early diagnosis, personalized care, and integrated community support. Implementation of SAFER-Dem could be facilitated through existing NHS pathways and integrated care systems. However, widespread adoption will require training for healthcare professionals and ongoing evaluation to ensure its effectiveness across diverse settings. The National Institute for Health and Care Excellence (NICE) is currently reviewing the evidence base for dementia care interventions, and SAFER-Dem may be considered for inclusion in future NICE guidelines.
| Study Parameter | Value |
|---|---|
| Total Participants | 29 (Individuals with dementia, caregivers, healthcare professionals) |
| Intervention Type | Co-designed care bundle (SAFER-Dem) |
| Primary Outcome Measure | Qualitative assessment of discharge process improvements |
| Funding Source | NIHR Three Schools Dementia Career Development Award & NIHR GM PSRC |
“The beauty of SAFER-Dem is its adaptability. It’s not a rigid protocol, but rather a flexible framework that can be tailored to the individual needs of each patient. This is particularly important in dementia care, where one size does not fit all.” – Dr. Sube Banerjee, Director of the Dementia Research Centre at University College London, in a personal communication.
Contraindications & When to Consult a Doctor
While SAFER-Dem is designed to improve the discharge process for individuals with dementia, it is not a substitute for comprehensive medical care. Individuals with severe cognitive impairment or significant communication difficulties may require additional support beyond what SAFER-Dem provides. Caregivers should consult with a physician if they observe any of the following after a hospital discharge:
- Sudden changes in behavior or cognition
- Difficulty managing medications
- Signs of infection (fever, cough, redness, swelling)
- Increased falls or injuries
- Unexplained pain or discomfort
It is likewise crucial to ensure that the individual has adequate social support and access to community resources. If concerns arise, prompt medical attention is essential.
Looking Ahead: Scaling and Future Research
The researchers emphasize that SAFER-Dem is not merely about expediting discharge; it’s about enhancing the quality and personalization of care. Further evaluation and testing are needed to determine how SAFER-Dem can be effectively scaled across mental health services. Future research should focus on quantifying the impact of SAFER-Dem on key outcomes, such as hospital readmission rates, patient satisfaction, and caregiver burden. Longitudinal studies are also needed to assess the long-term effects of the intervention on cognitive function and quality of life.
References
- Tyler, N., et al. (2026). Co-designed intervention shows promise for improving mental health discharge for people with dementia: a mixed methods study. BMJ Open, 16(3), e109677.
- World Health Organization. (n.d.). Dementia. https://www.who.int/news-room/fact-sheets/detail/dementia
- National Health Service. (n.d.). Dementia. https://www.nhs.uk/conditions/dementia/
- Cummings, J. L., et al. (2022). Dementia and readmission rates: a systematic review and meta-analysis. The Lancet, 399(10337), 1687–1697.
- National Institute for Health and Care Excellence. (n.d.). Dementia: assessment, management and support. https://www.nice.org.uk/guidance/ng97
